To demonstrate more specifically that the increased oxidative stress in the setting of β-arrestin-1 or -2 overexpression is due to increased Nox4 activity, we treated control CFs with apocynin, a non-specific Nox inhibitor, following infection with Ad-βarr1, Ad-βarr2 or Ad-Null. The gene discussed is ARRB2; the disease is infection.